Skip to content

ADHD, from behaviour to biology

ADHD, from behaviour to biology - ADHD, from behaviour to biology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39334
Enrollment
450
Registered
2013-02-12
Start date
2013-04-08
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD Attention Deficit Hyperactivity Disorder

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for parents: • No additional criteria if a child meets all of the inclusion criteria;General inclusion criteria for all subject groups (excluding parents): • Aged 6 through 18 years at first scan • Ability to speak and comprehend Dutch;Inclusion criteria for subjects with ADHD • Clinical DSM-IV diagnosis of ADHD, supported by the Diagnostic Interview Schedule for Children (DISC) ;Inclusion criteria for control subjects • No DSM-IV diagnosis, according to the DISC • No scores in the clinical range on any scale of the Child Behavior Checklist (CBCL) as reported by one of the parents.;Inclusion criteria for subjects with a psychiatric diagnosis but no diagnosis of ADHD • Any clinical DSM-IV diagnosis except ADHD, supported by the DISC interview • A score in the subclinical or clinical range of the CBCL subscale of Attention Problems as reported by one of the parents.

Exclusion criteria

Exclusion criteria: Mental retardation (IQ

Design outcomes

Primary

MeasureTime frame
Main study parameter/endpoint (1) Task related brain activity (BOLD-signal change) and connectivity measures from fMRI (2) Neuropsychological performance measures collected with computerized tasks

Secondary

MeasureTime frame
Secondary study parameters/endpoints (1) Resting-state functional connectivity, assessed with resting-state fMRI (2) Symptoms of ADHD from symptom rating scales (CBCL/TRF/SWAN) (3) White matter integrity, assessed using tract-based FA (Fractional Anisotropy) measures from DTI (Diffusion Tensor Imaging) (4) Genotype on risk genes for ADHD

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)